Consensus of Chinese Experts on the Diagnosis and Treatment of Cronkhite-Canada Syndrome(2025,Beijing)
10.12376/j.issn.2097-0501.2025.02.011
- VernacularTitle:Cronkhite-Canada综合征诊疗的中国专家共识意见(2025年,北京)
- Author:
Treatment And SECURITY
;
Jingnan LI
;
Jingyuan FANG
- Collective Name:Digestive Disease Branch of China Alliance for Rare Diseases/Beijing Association of Rare Disease Diagnosis
- Publication Type:Journal Article
- Keywords:
Cronkhite-Canada syndrome;
diagnosis and treatment;
consensus
- From:
JOURNAL OF RARE DISEASES
2025;4(2):221-231
- CountryChina
- Language:Chinese
-
Abstract:
Cronkhite-Canada syndrome(CCS)is a rare non-hereditary disease characterized by multiple gastrointestinal polyps and ectodermal abnormalities.Its etiology remains unclear,and there is a lack of a gold standard for diagnosis.Patients with CCS have a higher risk of developing gastrointestinal tumors compared to the general population.Early diagnosis is challenging,and the disease is prone to recurrence,necessitating long-term follow-up.The Digestive Disease Branch of China Alliance for Rare Diseases/Beijing Association of Rare Disease Diagnosis,Treatment and Security,in collaboration with the Rare Disease Collaborative Group of the Chinese Society of Gastroenterology,Chinese Medical Association,developed this consensus to provide cor-responding recommendations on the pathogenesis,clinical manifestations,diagnosis,and treatment of CCS.
